Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis of randomised trials

International Orthopaedics

Volumn 35, Issue 1, 2011, Pages 3-8

  Xue, Deting ^a   Zheng, Qiang ^a   Li, Hang ^a   Qian, Shengjun ^a   Zhang, Bo ^a   Pan, Zhijun ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ADULT; AGED; ARTICLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HETEROTOPIC OSSIFICATION; HIP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL HIP PROSTHESIS;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 78751632342     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-009-0886-y     Document Type: Article

References (25)

1. JJ Guo N Tang HL Yang L Qin KS Leung 2009 Impact of surgical approach on postoperative heterotopic ossification and avascular necrosis in femoral head fractures: a systematic review Int Orthop 10.1007/s00264-009-0849-3
2. SA Schmidt P Kjaersgaard-Andersen NW Pedersen SS Kristensen P Pedersen JB Nielsen 1988 The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial J Bone Jt Surg Am 70 834 838 1:STN:280:DyaL1c3ntlaluw%3D%3D
3. BJ Thomas 1992 Heterotopic bone formation after total hip arthroplasty Orthop Clin North Am 23 347 358 1:STN:280:DyaK383js12qtQ%3D%3D 1570146
4. EE Pakos EJ Pitouli PG Tsekeris V Papathanasopoulou K Stafilas TH Xenakis 2006 Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol Int Orthop 30 79 83 10.1007/s00264-005-0054-y 16482442
5. BC Neal A Rodgers T Clark H Gray IR Reid L Dunn SW MacMahon 2000 A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery Acta Orthop Scand 71 122 128 1:STN:280:DC%2BD3czgvFWmtA%3D%3D 10.1080/000164700317413076 10852316
6. E Rahme AN Barkun V Adam M Bardou 2004 Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs Drug Saf 27 1019 1042 10.2165/00002018-200427130-00004 15471508 (Pubitemid 39487065)
7. T Barthel B Baumann U Noth J Eulert 2002 Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam Acta Orthop Scand 73 611 614 10.1080/000164702321039543 12553505 (Pubitemid 36020901)
8. HJ Van der Heide WJ Rijnberg A Van Sorge A Van Kampen BW Schreurs 2007 Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty Acta Orthop 78 90 94 10.1080/ 17453670610013475 17453398 (Pubitemid 46570263)
9. JG Grohs M Schmidt A Wanivenhaus 2007 Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up Acta Orthop 78 95 98 10.1080/17453670610013484 17453399 (Pubitemid 46570264)
10. M Saudan P Saudan T Perneger N Riand A Keller P Hoffmeyer 2007 Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial J Bone Jt Surg Br 89 155 159 1:STN:280:DC%2BD2s7it1ehsw%3D%3D
11. AF Brooker JW Bowerman RA Robinson LH Riley Jr 1973 Ectopic ossification following total hip replacement. Incidence and a method of classification J Bone Jt Surg Am 55 1629 1632 1:STN:280:DyaE2M7hsVylsA%3D%3D
12. D Moher DJ Cook S Eastwood I Olkin D Rennie DF Stroup 1999 Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses Lancet 354 1896 1900 1:STN:280:DC%2BD3c%2FkvFCgtQ%3D%3D 10.1016/S0140-6736(99)04149-5 10584742
13. M Bradburn J Deeks D Altman 1998 Sbe24: metan-an alternative meta-analysis command Stata Tech Bull Reprints 8 86 100
14. RF Galbraith 1988 A note on graphical presentation of estimated odds ratios from several clinical trials Stat Med 7 889 894 1:STN:280: DyaL1czitFCjtQ%3D%3D 10.1002/sim.4780070807 3413368
15. JP Cella EA Salvati TP Sculco 1988 Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects J Arthroplast 3 229 234 1:STN:280:DyaL1M%2Fjs1aksg%3D%3D 10.1016/S0883-5403(88)80020-2
16. S Hofmann HJ Trnka H Metzenroth E Frank P Ritschl M Salzer 1999 General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty Orthopedics 22 207 211 1:STN:280:DyaK1M7lsV2gug%3D%3D 10037334
17. HJ Van der Heide RT Koorevaar BW Schreurs A van Kampen A Lemmens 1999 Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty J Arthroplast 14 796 799 10.1016/S0883-5403(99)90027-X (Pubitemid 29483244)
18. SS Kristensen P Pedersen NW Pedersen SA Schmidt P Kjaersgaard-Andersen 1990 Combined treatment with indomethacin and low-dose heparin after total hip replacement. A double-blind placebo-controlled clinical trial J Bone Jt Surg Br 72 447 449 1:STN:280:DyaK3c3ls1yltA%3D%3D
19. EW Weber R Slappendel ME Durieux R Dirksen H van der Heide M Spruit 2003 COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam Eur J Anaesthesiol 20 963 966 1:CAS:528:DC%2BD2cXltVarsg%3D%3D 10.1097/00003643-200312000-00005 14690098
20. S Goodman T Ma M Trindade T Ikenoue I Matsuura N Wong N Fox M Genovese D Regula RL Smith 2002 COX-2 selective NSAID decreases bone ingrowth in vivo J Orthop Res 20 1164 1169 1:CAS:528:DC%2BD38XotVWhsrY%3D 10.1016/S0736-0266(02) 00079-7 12472224 (Pubitemid 35363972)
21. AM Simon JP O'Connor 2007 Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing J Bone Jt Surg Am 89 500 511 10.2106/JBJS.F.00127 (Pubitemid 46365350)
22. HJ Van der Heide G Hannink P Buma BW Schreurs 2008 No effect of ketoprofen and meloxicam on bone graft ingrowth: a bone chamber study in goats Acta Orthop 79 548 554 10.1080/17453670710015562 18766490
23. C Wurnig E Schwameis P Bitzan F Kainberger 1999 Six-year results of a cementless stem with prophylaxis against heterotopic bone Clin Orthop Relat Res 361 150 158 10.1097/00003086-199904000-00020 10212608
24. RS Bresalier RS Sandler H Quan JA Bolognese B Oxenius K Horgan C Lines R Riddell D Morton A Lanas MA Konstam JA Baron 2005 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 1092 1102 1:CAS:528:DC%2BD2MXit1Kqu7o%3D 10.1056/NEJMoa050493 15713943 (Pubitemid 40365350)
25. DJ Cook CD Mulrow RB Haynes 1997 Systematic reviews: synthesis of best evidence for clinical decisions Ann Intern Med 126 376 380 1:STN:280: DyaK2s7pt1Grsw%3D%3D 9054282